Good Day BIO Newsletter

Before you begin your Thanksgiving prep, we recap last week's Clinical Trial Diversity Summit, how the "faceless middleman" is raising your healthcare costs, and promising news from USDA. (890 words, 4 minutes, 27 seconds)

A busy week in Washington begins, and we recap what you need to know about COP29, antimicrobial resistance, and more news on infectious disease. (1050 words, 5 minutes, 15 seconds)

Today, we explore BIO’s recommendations for how CMS can safeguard patient access under Medicare Part D, along with insights on a California Supreme Court case that could affect the complex drug development process, plus more news to know. (748 words, 3 minutes, 44 seconds).As we observe Veterans Day, we honor America’s veterans for their service and sacrifice. Check out our past coverage on how biotech supports veterans and ways to advocate for women veterans.

Rep. Hank Johnson discussed the impact of Georgia’s biosciences sector, and CPAC supports FTC action against PBMs. We have details, plus more news on bird flu, USDA biofuel grants, and more. Don’t forget to vote. (678 words, 3 minutes, 23 seconds)

Happy Halloween! We explain why open enrollment is scary. (391 words, 1 minutes, 57 seconds)

A busy Monday brings all the highlights from BIO's Patient and Health Advocacy Summit last week, plus what BIO's talking about at the World Food Prize event in Iowa tomorrow. (793 words, 3 minutes, 57 seconds)

A special Friday edition with new data on 340B spending and a New York Times feature highlighting Pivot Bio's outstanding work to support farmers and the planet with biotech. (437 words, 2 minutes, 11 seconds)

There’s a lot to know today—but we’re still under five minutes. Today, we look at what voters say about women’s health research and what the industry is saying about Colorado’s PDAB. Plus, a few more things we learned at BIF 2024 and op-eds from BIO member leaders. (809 words, 4 minutes, 2 seconds)

Day 2 of the BIO Investor Forum in San Francisco brought the policy outlook and the market outlook (and much more) – here's what we learned. (395 words, 1 minute, 58 seconds)

Day 1 of the BIO Investor Forum in San Francisco brought discussions on the fundraising environment and neurodegenerative disease targets and pipelines – we have recaps, plus more news to know today. (626 words, 3 minutes, 7 seconds)